1 / 35

In The Name of God

This presentation by Dr. SM Gatmiri highlights the increasing incidence and prevalence of Chronic Kidney Disease (CKD) in Iran, providing an overview of CKD definitions, stages, and the economic burden associated with End-Stage Renal Disease (ESRD). The presentation emphasizes the need for increased CKD education, early detection, and control of risk factors like hypertension and diabetes.

tweaver
Download Presentation

In The Name of God

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. In The Name of God CKD in Iran Presented by: SM Gatmiri, MD, Nephrologist Imam Khomeini Hospital, TUMSNRC

  2. CKD -A worldwide problem. -Rising incidence & prevalence.

  3. CKD Definition 1 -Kidney damage ≥3months, -Structural (pathological) or-Functional (composition of blood or urine) or-Imaging abnormalities -With or without decreased GFR.OR

  4. CKD Definition 2 -Presence of GFR<60 mL/min/1.73 m2≥3 months, -With or without other signs of kidney damage.

  5. Stage 1: NL GFR (>90 mL/min/1.73 m2) & persistent albuminuria (1.8% of the total US adult population). Stage 2: GFR 60 to 89 mL/min/1.73 m2 & persistent albuminuria (3.2%). Stage 3: GFR 30 & 59 mL/min/1.73 m2 (7.7%). Stage 4: GFR 15 & 29 mL/min/1.73 m2 (0.35%). Stage 5: GFR of <15 mL/min/1.73 m2 or ESRD (2.4%). 15.45%

  6. The number of ESRD in US has increased from -10,000 in 1973 to -86,354 in 1983, & to -527,283 as of December 31, 2007.

  7. In 2007 alone, 111,000 patients entered the US ESRD program. (Incidence: 440 PMP)

  8. Patients with ESRD consume a disproportionate share of health care resources.

  9. CKD, CHF & DM; Number of patients & costs; USA 2002 Numbers Costs 19% 5.8% 25.1% 20.7% 41.3% 48.1% 1.1% 7.8% Dialysis/Tx CHF Total Medicare DM CKD Collins AJ; USRDS database

  10. The total cost of the ESRD program in the US was approximately $35.32 billion in 2007.

  11. However CKD in the US, is under-diagnosed & under-treated.

  12. Iran Area: 1.648 million Sq Km Population : 68,017,860 Median Age : 24.23,Life Expectancy : 69.96 Total Health Expenditure of GDP : 6%

  13. ESRD in Iran Prevalence : 357PMP Incidence :66 PMP 12% CKD epidemiology in IranMitraMahdavi-Mazdeh- Assessment of HD patients …, Iran ;NDT (2007)

  14. Mean age difference in ESRD patients during last 10 years in Iran

  15. Sex difference in ESRD patients during last 10 years

  16. Causes of ESRD in the last 10 years in Iran

  17. male to female ratio is 1.33. Sex difference in ESRD patients during last 10 years in Iran

  18. Diabetes as the cause of ESRD in the last 10years

  19. HTN & DM as the causes of ESRD in the last 10 years in Iran

  20. The number Of ESRD will be doubled in next 10 years

  21. Annual RRT Cost with total health expenditure of GDP of 6% -Dialysis sessions: 800Billion R for 13000 Pts (>60,000,000 R/Pts) -R Tx drugs =500 B R -for 12000 Pts (>40,000,000 R/Pts)

  22. RRT program so far? CAPD HD centers Kidney Transplant

  23. Time to change our approach:decrease ESRD number or its postponing

  24. Population-Based Screening CKD in Iran: Mahdavi-Mazdeh :IJKD.vol:4,no:4, 2010

  25. What is Solution? We Should push for a CKD education To take serious high NL Cr To take serious HTN &Diabetes management CKD should be viewed as the third part of the deadly triangle with DM and CVD affecting the health & welfare of the general population

  26. What is Our Common TaskAs -Nephrologists -Internist -GPs -Health Authorities?

  27. Education 1. Primordial Prevention : Healthy Diet, Changes in Social, Cultural and Personal Habits 2. Early Detection, Referral and Control of HTN & DM Public Education Professional (Health Care Personnel) Education

  28. CKD Patients receiving ACE-Is/ARBs NHANES III 1988–1994 & NHANES 1999–2002 patients age 60 & older; patients with eGFRs of less than 15 ml/min/1.73 m2 are excluded. *Sample size less than 30, or coefficient of variation is not less than 30 percent.

  29. Vascular Access: New Medical Evidence Form 2728 Data, May 2005-Dec 2006 82% of patients are using a catheter as their first outpatient access!!!! Only 13% of incident HD patients used a fistula as their first access. Assessment of HD patients …, Iran ;NDT (2007)

  30. Vascular Access • AVF use in Canadian prevalent (53%) and incident (26%)patients . • In Europe [prevalent(74%), incident(50%) • AVF is the advocated access route in Iran [prevalent (91%), incident(37.5%)in Tehran]. Assessment of HD patients …, Iran ;NDT (2007)

  31. Message: -CKD & ESRD is increased & highly prevalent -A strong CVD risk factor.

  32. Message -We can detect CKD with simple tests & there are treatments for CKD.

  33. Message: -ESRD is increasing, more than increases in number of HD facility & Tx.

  34. Message -We should consider CKD prevention & place initial focus on strategies that slow disease progression to postpone RRT.

More Related